|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-5-4
|
|
pubmed:abstractText |
The purpose of this multicenter randomized, open-label, parallel-group study was to assess whether the addition of low-dose dexamethasone to ondansetron results in improved control of chemotherapy-induced emesis in patients undergoing first-line chemotherapy with high-dose epirubicin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-41
|
|
pubmed:dateRevised |
2008-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:10778764-Antibiotics, Antineoplastic,
pubmed-meshheading:10778764-Antiemetics,
pubmed-meshheading:10778764-Breast Neoplasms,
pubmed-meshheading:10778764-Dexamethasone,
pubmed-meshheading:10778764-Drug Therapy, Combination,
pubmed-meshheading:10778764-Epirubicin,
pubmed-meshheading:10778764-Female,
pubmed-meshheading:10778764-Humans,
pubmed-meshheading:10778764-Middle Aged,
pubmed-meshheading:10778764-Ondansetron,
pubmed-meshheading:10778764-Serotonin Antagonists,
pubmed-meshheading:10778764-Vomiting
|
|
pubmed:articleTitle |
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study.
|
|
pubmed:affiliation |
Agii Anargiri Cancer Hospital, Kifissia, Athens, Greece. hecogaga@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
